Yunnan Baiyao Buys Rights on KA-1641 Drug Yunnan Baiyao Group (SHE:000538) bought the rights of antibody drug KA-1641 from Kangyuan Bochuang Biotechnology (Beijing), according to the company's filing ...
Source LinkYunnan Baiyao Buys Rights on KA-1641 Drug Yunnan Baiyao Group (SHE:000538) bought the rights of antibody drug KA-1641 from Kangyuan Bochuang Biotechnology (Beijing), according to the company's filing ...
Source Link
Comments